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Summary
Cerebrospinal ﬂuid (CSF) ﬂow dynamics, which sup-
posedly have a strong relationship with chronic cere-
brospinal venous insufﬁciency (CCSVI), might be ex-
pected to be affected in multiple sclerosis (MS) pa-
tients. In this study, CSF ﬂow at the level of the cerebral
aqueduct was evaluated quantitatively by phase con-
trast magnetic resonance imaging (PC-MRI) to deter-
mine whether CSF ﬂow dynamics are affected in MS pa-
tients. We studied 40 MS patients and 40 healthy con-
trols using PC-MRI. We found signiﬁcantly higher cau-
docranial (p=0.010) and craniocaudal CSF ﬂow volumes
(p=0.015) and stroke volume (p=0.010) in the MS pa-
tients compared with the controls. These ﬁndings may
support the venous occlusion theory, but may also be
explained by atrophy-dependent ventricular dilatation
independent of the venous theory in MS patients.
KEY WORDS: cerebrospinal ﬂuid, chronic cerebrospinal venous in-
sufﬁciency, magnetic resonance imaging, multiple sclerosis
Introduction
Cerebrospinal ﬂuid (CSF) is mainly produced by the
choroid plexus (80-90%), but also most likely by the
parenchyma of the brain and spinal cord (10-20%). CSF
ﬂows through the ventricular system and then into the
subarachnoid space. According to the most widely ac-
cepted theory, CSF absorption occurs mainly through
the arachnoid villi into the venous system. However, a
new theory (1) suggests that absorption of CSF also oc-
curs through capillaries within the brain parenchyma.
Recent studies investigating venous ﬂow abnormalities
in patients with multiple sclerosis (MS) reveal a strong
relationship between MS and the venous system (2-5).
Theoretically, CSF circulation should be affected by ve-
nous obstruction. Venous obstructions causing blood
ﬂow insufﬁciency have been shown to cause hydro-
cephaly (6,7). A study performed by Zamboni et al. (8)
revealed that CSF ﬂow is affected in MS patients with
chronic cerebrospinal venous insufﬁciency (CCSVI). In
another study, no alteration was observed in aqueductal
CSF ﬂow in MS patients (9). 
In the present study, CSF ﬂow at the level of the cere-
bral aqueduct was evaluated quantitatively by phase
contrast magnetic resonance imaging (PC-MRI) to de-
termine whether CSF ﬂow dynamics are affected in MS
patients.
Materials and methods
MS patients and control group
Between March and August 2010, 40 patients diag-
nosed with MS according to the Poser (10) and McDon-
ald (11) criteria [32 with relapsing-remitting MS (RRMS)
and 8 with secondary progressive MS (SPMS)] were re-
cruited consecutively from the Neurology Department at
the Haseki Research and Education Hospital in Istanbul
and enrolled in this study. All the patients were on dis-
ease-modifying therapy. The inclusion criteria were as
follows: a RR or SP disease course; an expanded dis-
ability status scale (EDSS) (12) score between 1 and
8.5; age between 18 and 58 years; disease duration be-
tween 4 and 240 months; no history of any other neuro-
logical disease; and current remission status of the dis-
ease. Exclusion criteria were: acute relapse or steroid
treatment within the 30 days preceding study entry and
pre-existing medical conditions associated with brain
pathologies, such as neurodegenerative disorders, alco-
hol abuse, and other conditions. The control group con-
sisted of 40 neurologically normal individuals who were
sex-matched and age-matched (±2 years) with the MS
patients. 
Informed consent was obtained from the patients after
ethics committee approval had been obtained and de-
tailed information about the study had been provided. 
PC-MRI technique
MR images were acquired using a 1.5-T unit (Philips
Achieva, Best, The Netherlands) with an 8-channel
head coil. All cases were ﬁrst evaluated using routine
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axial T1- and T2-weighted turbo spin-echo (TSE) cra-
nial sequences. For quantitative investigation of CSF
ﬂow, PC-MRI was performed in the axial plane, which
was perpendicular to the cerebral aqueduct (Fig. 1). For
axial plane images (Fig. 2), the following parameters
were used: TR=24 ms; TE=14 ms; cross-section thick-
ness = 4 mm; number of signal averages (NSA) = 2; ﬂip
angle = 15°; ﬁeld of view (FOV) = 100 mm x 100 mm;
matrix = 260×182; and velocity encoding (Venc) = 20
cm/s. These parameters generated 12 time points per
cardiac cycle. Caudocranial direction denoted positive
and craniocaudal direction negative ﬂow. Cardiac trig-
gering was performed retrospectively using finger
plethysmography.
Imaging analysis
All MRI images were evaluated by two radiologists blind-
ed to the study subjects’ clinical conditions (Y.G. and
S.A., with 5 and 10 years’ experience, respectively). The
ﬁndings of these two radiologists were not signiﬁcantly
different.
Quantitative analysis of CSF ﬂow was performed using
“2D Q-ﬂow” phase contrast MR angiography software
on the Philips MR workstation (Philips, Best, The
Netherlands) with axial plane images obtained at the
level of the cerebral aqueduct. First, phase-contrast im-
Y. Gorucu et al.
216 Functional Neurology 2011; 26(4): 215-222 
Figure 1 - PC-MR image in the axial plane positioned perpendi-
cular to the cerebral aqueduct, which is necessary for measure-
ment of CSF ﬂow.
Figure 2 - Rephase (a), magnitude (b), and phase (c) images perpendicular to the ampulla region of the cerebral aqueduct.
a b
c
ages were transferred to the 2D Q-Flow software. After
sufﬁcient magniﬁcation of images (always using a mag-
niﬁcation ratio of 400%), a region of interest (ROI) was
placed manually to completely cover the cerebral aque-
duct in every image (Fig. 3). Thereafter, graphs of ﬂow-
time, peak velocity-time, mean velocity-time and maxi-
mum velocity-time were obtained for one cardiac beat
with 2D Q-Flow. The maximum velocity-time graph is
shown in ﬁgure 4.
With the exception of peak velocity-time, in all the
graphs, positive values (diastolic) indicate caudocranial
CSF ﬂow and negative values (systolic) craniocaudal
CSF ﬂow. RR intervals are also indicated. Furthermore,
on the right-hand side of the graphs, CSF ﬂow data (cal-
culated by the software for one cardiac beat) are given.
These data are: 
– “stroke volume (ml/min)”: elsewhere (13), this param-
eter is calculated as the mean of the absolute value of
the caudocranial and craniocaudal CSF ﬂow volumes,
but in our study, it was deﬁned as net CSF ﬂow volume
(i.e. the difference between “forward ﬂow volume” and
“backward ﬂow volume”); 
– “forward ﬂow volume (ml/min)”: caudocranial CSF ﬂow
volume during diastole; 
– “backward ﬂow volume (ml/min)”: craniocaudal CSF
ﬂow volume during systole; 
– “regurgitant fraction (%)”: the ratio of the smaller to the
larger value, between the “backward ﬂow volume” and
“forward ﬂow volume”, however, in the present study this
parameter was deﬁned as the ratio of the caudocranial
CSF ﬂow dynamics and MS
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Figure 3 - ROI placement on the cerebral aqueduct, after sufﬁcient magniﬁcation of phase-contrast images with the axial plane per-
pendicular to cerebral aqueduct. 
Figure 4 - Maximum velocity-time graph following ROI placement on the cerebral aqueduct in phase-contrast images obtained [posi-
tive values (diastolic) show CSF ﬂow velocity in the caudocranial direction and negative values (systolic) CSF ﬂow velocity in the cra-
niocaudal direction] and CSF ﬂow data [stroke volume (ml), forward ﬂow volume (ml), backward ﬂow volume (ml), regurgitant fraction
(%), absolute stroke volume (ml),  mean ﬂux (ml/s), stroke distance (cm) and mean velocity (cm/s)] calculated for one cardiac beat
by 2D-Q Flow software.
CSF ﬂow volume to the craniocaudal CSF ﬂow volume; 
– absolute stroke volume (ml/min)”: the sum of “back-
ward ﬂow volume” and “forward ﬂow volume”, meaning
total CSF volume passing through the cerebral aque-
duct; 
– “mean ﬂux (ml/s)”: mean CSF ﬂow volume per second; 
– “mean velocity (cm/s)”: mean CSF ﬂow velocity [posi-
tive values (diastolic) show caudocranial CSF ﬂow, neg-
ative values (systolic) craniocaudal CSF ﬂow.] (Fig. 4). 
As indicated above, in this study, stroke volume is de-
ﬁned as net CSF ﬂow volume, i.e. the difference be-
tween the caudocranial and craniocaudal ﬂow volumes.
If the net CSF ﬂow was directed towards the third ven-
tricle, the net CSF ﬂow volume values were evaluated
as positive. Conversely, if the net CSF ﬂow was direct-
ed towards the fourth ventricle, the net CSF ﬂow volume
values were deemed to be negative. 
The MS group and control group data were compared.
The data of the RRMS group were compared with those
recorded in the control-rr subgroup; in addition, the data
of the SPMS group were compared with those recorded
in the control-sp subgroup, even though the number of
patients included in this subgroup analysis was not suf-
ﬁcient to draw any conclusions. 
For this purpose, 32 of the 40 control group subjects
were selected as control-rr and the remaining 8 subjects
as control-sp; this was done taking great care to ensure
sample size, age and sex matching of the MS and rela-
tive control groups. 
In addition, the RRMS patients were compared with the
SPMS patients in relation to the following parameters:
age, heart rate, aqueductal area, mean velocity, peak
systolic and diastolic velocity, regurgitant fraction, cau-
docranial and craniocaudal ﬂow volumes, stroke vol-
ume, net CSF ﬂow volume and net CSF ﬂow direction.
The comparison of the two MS subgroups also included
the parameters disease duration and EDSS scores. We
also analysed convenient parameters in ml/min in order
to study the effect, on the results, of cardiac beat differ-
ences between the subjects. 
Statistical analyses
The Kolmogorov-Smirnov test was used to test the
equality of the distribution of variables, unless stated oth-
erwise. Groups were also compared for net CSF ﬂow di-
rection and sex using Pearson’s chi-squared or Fisher’s
exact test statistic. Other differences between groups
were assessed using Student’s t-test or the Mann-Whit-
ney U-test, as appropriate. A p-value <0.05 was consid-
ered to indicate statistical signiﬁcance in all analyses.
Results
The various between-group comparisons revealed no
statistically signiﬁcant differences in distribution of sex or
net CSF ﬂow direction (i.e. distribution of subjects be-
tween caudocranial and craniocaudal direction) (Table I).
Comparison of parameters in MS patients versus
control group
Mean velocity was signiﬁcantly different between the
MS patients and the control group (p=0.046). Mean ve-
locity was 0.017 cm/s in the MS patients (caudocranial
direction) versus -0.055 cm/s in the controls (craniocau-
dal direction). Caudocranial flow volume (ml/min)
(p=0.010), craniocaudal ﬂow volume (ml/min) (p=0.015)
and stroke volume (ml/min) (p=0.010) were found to be
signiﬁcantly higher in the MS patients than in the control
group. The other parameters compared showed no sta-
tistically signiﬁcant difference between these two groups
(Table II).
Comparison of parameters in RRMS patients
versus control-rr subgroup
Caudocranial ﬂow volume (µl/beat) (p=0.034), (ml\min)
(p=0.014), craniocaudal ﬂow volume (ml\min) (p=0.014)
and stroke volume (µl/beat) (p=0.046), (ml\min)
(p=0.013) were signiﬁcantly higher in the RRMS pa-
Y. Gorucu et al.
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Table I - Between-group comparisons for distribution of sex and net CSF ﬂow direction.
Sex Net CSF ﬂow dırectıon
Male Female p-value Caudocranıal Cranıocaudal p-value
MS (n:40) 16 24 18 22
GROUP (n:80) CONTROL (n:40) 16 24 1.000 13 27 0.251
MS TYPE (n:40) RRMS (n:32) 11 21 0.229 12 20 0.110
SPMS (n:8) 5 3 6 2
RRMS & RRMS (n:32) 11 21 12 20CONTROL-rr 1.000 0.424
(n:64) CONTROL-rr (n:32)  11 21 9 23
SPMS & SPMS (n:8) 5 3 6 2CONTROL-sp 1.000 0.608
(n:16) CONTROL-sp (n:8) 5 3 4 4
Abbreviations: MS=multiple sclerosis; RRMS=relapsing-remitting multiple sclerosis; SPMS=secondary progressive multiple sclerosis;
CSF=cerebrospinal ﬂuid.
CSF ﬂow dynamics and MS
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Table II - Between-group comparisons of the parameters age, heart rate, aqueductal area, mean velocity, peak systolic and
diastolic velocity, regurgitant fraction, caudocranial and craniocaudal ﬂow volumes, stroke volume, net CSF ﬂow volume.
MS & CONTROL RRMS & CONTROL-rr SPMS & CONTROL-sp
MS CONTROL RRMS CONTROL- SPMS CONTROL-
Parameters (n:40) (n:40) (n:32) rr (n:32) (n:8) sp (n:8)
Median Median Median Median Median Median
Mean Mean p-value Mean Mean p-value Mean Mean p-value
±SD ±SD ±SD ±SD ±SD ±SD
36.5 37.0 35.0 36.0 44.0 45.5
Age years 37.6 37.8 0.919 36.2 36.4 0.923 43.1 43.1 1.000
±10.2 ±10.2 ±10.3 ±10.3 ±7.9 ±8.0
70.0 68.5 69.5 70.5 75.5 64.5
Heart rate beats/min 73.2 70.4 0.409 73.6 70.9 0.499 71.6 68.3 0.563
±15.8 ±14.3 ±16.6 ±14.6 ±12.8 ±13.9
4.5 5.2 4.5 5.2 4.4 5.7Aqueductal
mm2 4.8 5.1 0.507 4.8 4.9 0.710 5.1 5.7 0.494area
±1.6 ±1.5 ±1.7 ±1.4 ±1.5 ±1.9
-0.002 -0.076 -0.004 -0.096 0.123 0.004
Mean velocity cm/s 0.017 -0.055 0.046 -0.003 -0.070 0.099 0.095 0.007 0.294
±0.183 ±0.126 ±0.183 ±0.133 ±0.169 ±0.068
-9.9 -8.8 -10.3 -9.0 -8.2 -7.8Peak systolic
cm/s -10.2 -9.3 0.413 -10.6 -9.6 0.398 -8.4 -8.1 0.834velocity
±4.0 ±2.7 ±4.1 ±2.8 ±2.8 ±1.8
8.2 7.7 8.9 7.7 7.6 7.9Peak diastolic
cm/s 9.1 7.9 0.086 9.4 8.0 0.065 7.7 7.7 0.674velocity
±3.6 ±2.4 ±3.7 ±2.5 ±2.5 ±2.5
Regurgitant 98.1 93.5 97.8 90.6 111.0 100.1
fraction %/beat 98.3 95.0 0.388 96.1 94.1 0.655 106.9 98.7 0.058±17.5 ±15.7 ±18.3 ±17.1 ±10.9 ±7.8
43.00 36.00 44.00 34.50 39.00 41.00
µl/beat 48.45 36.30 0.061 50.25 34.38 0.034 41.25 44.00 0.753
Caudocranial ±28.85 ±17.38 ±31.02 ±15.12 ±17.39 ±24.20
ﬂow volume 3.11 2.47 3.32 2.38 2.90 2.74
ml/min 3.33 2.43 0.010 3.40 2.34 0.014 3.04 2.76 0.753
±1.84 ±1.01 ±1.91 ±0.93 ±1.60 ±1.29
-45.50 -39.00 -47.50 -36.00 -33.50 -40.50
µl/beat -48.68 -38.58 0.137 -50.84 -37.09 0.062 -40.00 -44.50 0.674
Craniocaudal ±27.81 ±17.59 ±29.24 ±15.53 ±20.41 ±24.59
ﬂow volume
-3.24 -2.68 -3.38 -2.62 -2.75 -2.71
ml/min -3.34 -2.57 0.015 -3.44 -2.51 0.014 -2.94 -2.79 0.834
±1.74 ±1.01 ±1.74 ±0.93 ±1.80 ±1.33
45.00 36.25 47.00 35.00 36.25 41.00
µl/beat 48.56 37.38 0.103 50.55 35.64 0.046 40.63 44.31 0.713
±28.17 ±17.26 ±29.98 ±15.02 ±18.71 ±24.33
Stroke volume 3.11 2.64 3.27 2.63 2.90 2.73
ml/min 3.33 2.49 0.010 3.42 2.42 0.013 2.99 2.78 0.753
±1.78 ±0.99 ±1.81 ±0.91 ±1.69 ±1.30
-1.00 -2.00 -1.00 -3.00 3.00 0.00
µl/beat -0.20 -2.18 0.152 -0.63 -2.59 0.232 1.50 -0.50 0.080
Net CSF ±6.76 ±5.39 ±7.20 ±5.79 ±4.57 ±3.07
ﬂow volume
-0.06 -0.16 -0.09 -0.19 0.22 0.02
ml/min -0.01 -0.13 0.179 -0.04 -0.16 0.315 0.11 -0.03 0.093
±0.48 ±0.39 ±0.50 ±0.42 ±0.34 ±0.19
Abbreviations: MS=multiple sclerosis; RRMS=relapsing-remitting multiple sclerosis; SPMS=secondary progressive multiple sclerosis;
CSF=cerebrospinal ﬂuid.
tients compared with the control-rr subgroup. There was
no statistically signiﬁcant difference between the two
groups in the other parameters compared (Table II).
Comparison of parameters in SPMS patients
versus control-sp subgroup
No statistically signiﬁcant difference in any parameter
was found between these two groups (Table II).
Comparison of parameters in RRMS patients
versus SPMS patients 
The mean disease duration was 62.31 (±56.46) months
in the RRMS patients and 133.50 (±51.49) months in the
SPMS patients, thus this parameter was signiﬁcantly
higher in the SPMS patients (p=0.002). The mean
EDSS score was 1.91 (±1.00) in the RRMS patients and
5.94 (±1.78) in the SPMS patients and therefore signiﬁ-
cantly higher in the SPMS patients (p<0.001). No statis-
tically signiﬁcant difference between the RRMS and
SPMS groups was found in any of the other parameters
compared (data not shown in Table II).
Discussion
Reliable ﬂow quantiﬁcation is reported to be feasible if
the diameter of the aqueduct lumen is greater than 1.5
mm2 (14). In our study, the lowest ROI area was 1.7
mm2. The mean ROI area was 4.8 mm2 in the MS pa-
tients and 5.1 mm2 in the control group, and was not
found to be signiﬁcantly different between these two
groups.
Cardiac gating can be achieved either prospectively or
retrospectively. In this study we used retrospective gat-
ing, in which the ECG is recorded as the scanner con-
tinuously obtains imaging data. At the end of the scan,
software ﬁts the imaging data into the most appropriate
portion of the ECG to create the image. In prospective
triggering, the scanner uses the QRS complex of the
ECG as a signal to begin imaging; there is a necessary
“dead zone” at the end of each cardiac cycle for the
scanner to await the next QRS complex. The advantage
of retrospective gating is that it covers the entire cardiac
cycle (15).
Nowadays 3.0 T MR imaging of the brain is becoming
more widely accepted. 3.0 T MR machines have been
used in two other studies (8,9), whereas we used the 1.5
T MR machine in our study. Almost all the CSF ﬂow pa-
rameters (except for CSF production) have proved sta-
tistically signiﬁcantly higher when obtained with the 3.0
T than with the 1.5 T MR equipment (16).
Time points per single cardiac cycle can differ due to
heart rate. Both 14-16 time points (17) and 32 time
points (8,9) have been used in various studies investi-
gating CSF ﬂow dynamics. There is no publication in the
English-language literature that explores alterations in
CSF ﬂow parameters due to different time point usage.
Additionally, our ﬁndings are largely consistent (taking
into account differences due to demographic and tech-
nical factors) with ﬁndings presented in other studies in
the literature.
In a study of 16 RRMS patients with CCSVI, Zamboni et
al. (8) found net CSF ﬂow at the cerebral aqueduct to be
reduced. In addition, they found a signiﬁcant relationship
between decline in net CSF ﬂow and CCSVI severity.
They concluded that CCSVI in MS patients affects CSF
dynamics. However, Sunderström et al. (9) performed a
study in 20 RRMS patients and, unlike Zamboni et al.
(8), did not detect any signiﬁcant narrowing in neck
veins with PC-MRI or contrast-enhanced MR angiogra-
phy. In the present study, CSF ﬂow parameters, such as
net CSF ﬂow volume and stroke volume, evaluated with
PC-MRI, were not found to be statistically signiﬁcantly
different between MS patients and the control group.
Craniocaudal CSF flow volume per cardiac beat
(µl/beat) was higher in the RRMS patients compared
with the control-rr subgroup, but this difference was not
statically signiﬁcant (p=0.062). This ﬁnding is consistent
with the study of Zamboni et al. (8). However, in contrast
to our study, Zamboni et al. (8) found no difference in
caudocranial CSF ﬂow volume (µl/beat). Furthermore,
even though the net CSF ﬂow volume (µl/beat) was
found to be slightly lower in our RRMS patients, this dif-
ference was not statistically signiﬁcant; this ﬁnding con-
trasts with the report of Zamboni et al. (8). Sundström et
al. (9) found no difference in the net CFS ﬂow volume
(ml/min) in RRMS patients compared with controls,
which is consistent with our result. Unlike us, Sund-
ström et al. (9) found no difference in the stroke volume
(µl/beat) in RRMS patients versus controls. Additionally,
with regard to the parameters not calculated in the
abovementioned studies, we failed to detect differences
in some of these parameters, namely mean velocity,
peak systolic and peak diastolic velocities and regurgi-
tant fraction, whereas differences did emerge in others,
namely the craniocaudal and caudocranial CSF ﬂow vol-
umes (ml/min), and stroke volume (ml/min). Craniocau-
dal and caudocranial CSF ﬂow volume (ml/min), and
stroke volume (ml/min) were found to be higher in the
RRMS patients than the control-rr subgroup. 
No PC-MRI study investigating CSF dynamics in SPMS
patients and controls could be found in the literature.
Granted that the small number of SPMS patients in our
study precluded any meaningful conclusions, our analy-
sis nevertheless failed to reveal any statistically signiﬁ-
cant difference in any of the parameters compared.
However, it is possible that a PC-MRI study of CSF ﬂow
in a larger number of SPMS patients could show a sta-
tistically signiﬁcantly increased CSF regurgitant fraction
in the caudocranial direction. In our study, it was found
to be higher in SPMS patients (106.7%) than in the con-
trol-spms subgroup (98.7%), but this difference was not
statistically signiﬁcant (p=0.058). This ﬁnding may be
explained by venous hemodynamic impairment in MS
patients, which was mentioned in Zamboni’s report (8).
We think that this hemodynamic impairment causes a
mild deﬁcit in CSF reabsorption through the sinuses
and, therefore, changes in these parameters. Given the
caudocranial direction of net CSF ﬂow volume in SPMS
patients, we suggest that CSF reabsorption occurs more
in transependymal sites than in the venous sinuses.
When comparing RRMS patients with the control-rr sub-
group, statistically signiﬁcant hyperdynamic properties
(increased caudocranial and craniocaudal ﬂow volumes
and stroke volume) were observed; these differences
did not emerge when comparing the SPMS patients with
the control-sp subgroup. This can be explained as fol-
lows: the mean age of the healthy control-sp subgroup
Y. Gorucu et al.
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was higher than that of the control-rr subgroup, albeit
not statistically signiﬁcantly (p=0.095). The literature re-
ports that intracranial CSF volume increases after a per-
son’s twenties (18), and that the ratio of cerebral ventric-
ular volume to total brain volume increases with aging
(19); a strong correlation between aqueductal CSF ﬂow
and ventricular morphology, especially between total
ventricular volume and third ventricle width, has also
been reported (20). Furthermore, various studies have
reported an increase in CSF ﬂow dynamics due to ag-
ing, albeit not statistically signiﬁcant (21-23). Consistent
with the literature, we found CSF ﬂow volume (cau-
docranial and craniocaudal ﬂow volumes and stroke vol-
ume) to be higher (albeit not statistically signiﬁcantly) in
the control-sp subgroup, which has an older mean age
compared with the control-rr subgroup. This explains the
absence of a statistically signiﬁcant difference between
SPMS patients and the control-sp subgroup. 
Although craniocaudal (ml/min) and caudocranial CSF
ﬂow volume (ml/min), and stroke volume (ml/min) were
higher in MS patients, the fact that peak systolic and di-
astolic velocities were not signiﬁcantly different between
MS patients and controls may be seen as controversial.
But peak systolic or peak diastolic velocities (cm/s) are
not the only parameters used in calculation of CSF ﬂow
volume (ml/min). Heart rate and aqueduct area are also
used in the formula to calculate CSF ﬂow volume. The
aqueduct area was smaller in the MS patients
(p=0.507), whereas peak systolic and peak diastolic ve-
locities, and heart rate were higher in this group, howev-
er, these differences were not statistically signiﬁcant
(p=0.411, p=0.086 and p=0.409 respectively). These pa-
rameters in MS patients that were increased, but not
statistically signiﬁcantly, are associated with craniocau-
dal (ml/min) and caudocranial CSF flow volume
(ml/min), and stroke volume (ml/min), which, instead,
were found to be statistically signiﬁcantly higher in MS
patients than the control group.
We think that the increased craniocaudal and caudocra-
nial CSF ﬂow volume (ml/min) and stroke volume
(ml/min) in MS patients can be explained in two ways.
First, by the venous hemodynamic impairment in MS pa-
tients mentioned in Zamboni’s report (8). Although we
did not investigate this phenomenon in our study, we
suggest that it causes a mild deﬁcit in CSF reabsorption
through the sinuses and an increase in the above pa-
rameters. Another ﬁnding supports this hypothesis: the
CSF regurgitant fraction was found to be slightly higher
in the MS patients than the control group, however, this
difference was not statistically signiﬁcant. Secondly, al-
though this was not estimated in our study, an atrophy-
dependent ventricle volume increase in the MS patients
may have caused the increase in the above values, giv-
ing rise to an increased mild hyperdynamic situation in-
dependent of the venous theory. This idea is supported
by Chiang et al. (20) who found a relationship between
ventricular morphology and aqueductal CSF ﬂow in
healthy subjects and in patients with communicating hy-
drocephalus. They concluded that aqueductal CSF ﬂow
should not be regarded independently of ventricular
morphology. At the same time, Zamboni et. al (8)
showed that the volume of the lateral and third ventricles
was increased in MS patients with CCSVI.
Although we had more subjects in our study than others,
if more RRMS, SPMS, and primary progressive MS pa-
tients could be enrolled in each of these groups, this
would allow a more efﬁcient study to be performed. We
did not perform Doppler or magnetic resonance venog-
raphy, and therefore have no information about the jugu-
lar and azygos veins. Additionally, the ventricle volumes
were not estimated, which weakens our study. The use
of 1.5 T MR instead of 3.0 T MR and of 12 time points (a
low number) were further weaknesses of our study.
There is a clear need for additional studies with more
subjects, assessment of the cerebral venous system,
cerebral perfusion imaging and estimation of ventricle
volume values.
In conclusion, in the present study, the caudocranial and
craniocaudal CSF ﬂow volumes and stroke volume were
found to be signiﬁcantly higher in the MS patients.
These ﬁndings may support the venous theory in MS
patients, but may also be explained by atrophy-depend-
ent ventricular dilatation independent of the venous the-
ory in MS patients. Further studies are needed.
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